Jon Hamilton

Researchers have found the first drug to treat progeria, an extremely rare genetic disease that causes children to age so rapidly that many die in their teens.

The drug, called lonafarnib, is not a cure. But in a study published Monday of 28 children, it reversed changes in blood vessels that usually lead to heart attacks and strokes.

An experimental drug that helps people who have Fragile X syndrome is raising hopes of a treatment for autism.

The drug, called arbaclofen, made people with Fragile X less likely to avoid social interactions, according to a study in Science Translational Medicine. Researchers suspect it might do the same for people with autism.

BPA could be making kids fat. Or not.

That's the unsatisfying takeaway from the latest study on bisphenol A — the plastic additive that environmental groups have blamed for everything from ADHD to prostate disease.

Unfortunately, the science behind those allegations isn't so clear. And the new study on obesity in children and teens is no exception.

Listen up, baby boomers. The government wants every one of you to get tested for the hepatitis C virus.

The Centers for Disease Control and Prevention made a sweeping recommendation official amid growing concern about the estimated 2 million boomers infected with the virus, which can cause cirrhosis and liver cancer. The advice was published in the latest Morbidity and Mortality Weekly Report.

After a tsunami disabled the Fukushima Dai-ichi plant in March of 2011, residents of the nearby city of Minamisoma, just 14 miles from the plant, were evacuated.

But within a few months, most returned to their homes. Still, many communities near the plant have remained skeptical and concerned about possible radiation exposure.

To find out how much radiation exposure these people have received, Japanese researchers measured levels of radioactive cesium in nearly 10,000 residents starting six months after the incident.